At Rare Molecule Foundry (RMF), we harness the power of advanced AI models to design molecules, proteins, enzymes, and peptides in silico.
At Rare Molecule Foundry (RMF), we design molecules, proteins, enzymes, and peptides in-silico using cutting-edge AI models. Our proprietary technology accelerates the discovery and optimization of novel compounds for biopharma, research, and drug development—reducing time, cost, and uncertainty in the innovation pipeline.
Whether you’re developing next-generation therapeutics, advancing synthetic biology, or exploring novel biomaterials, RMF provides the computational power to model, refine, and validate molecular structures before they reach the lab.
From concept to candidate, we bring precision-driven design to molecular engineering—helping you build the future of science.
Ready to accelerate discovery and push the boundaries of science?
We leverage advanced AI-driven models to generate and refine novel molecules with unprecedented speed and accuracy—reducing trial-and-error experimentation.
Our computational platform helps biopharma and research teams identify viable candidates faster, optimizing for stability, efficacy, and manufacturability before synthesis.
We design molecules tailored to specific functions, whether for therapeutics, enzymatic engineering, or synthetic biology applications—ensuring targeted, high-performance solutions.
RMF’s computational approach complements traditional wet lab research, streamlining workflows and bridging the gap between theory and experimentation.
By unlocking new frontiers in molecular engineering, RMF empowers teams to push the boundaries of science—faster, smarter, and with greater confidence.
Whether you’re a biotech startup, a pharmaceutical leader, or a research institution, Rare Molecule Foundry is your partner in AI-driven molecular design.
Ready to accelerate discovery and push the boundaries of science?
Let’s collaborate. Contact us today to explore how RMF can power your next breakthrough.
Utilizing generative AI, we’re designing molecules that can modulate gap junctions—crucial for intercellular communication. Applications include regenerative medicine, cardiac therapies, oncology, and aging.
Developing diverse molecules targeting multiple pathways involved in neurodegeneration, offering hope for treating Parkinson’s and Alzheimer’s, especially in early-onset cases.
Pioneering cancer treatments, including protein binders targeting specific cancer-related proteins for inhibition, drug conjugates, and immune cell engagement.
Developing AI-powered enzyme design workflows to optimize and create enzymes for breaking down plastics, contributing to a sustainable biorecycling economy.
Enhancing enzymes in food production through AI-driven iterative design, improving catalytic activity and efficiency in food manufacturing processes.
Designing AI-driven proteins to sequester tetrodotoxin, a potent neurotoxin found in blue-ringed octopus venom, aiming to develop an effective antidote.
Developing a novel inhibitor to prevent avian influenza infection in host cells, designed for nasal spray delivery to reduce symptoms and transmission rates.
Our process is designed to guide you every step of the way. From initial consultation to personalized strategy development.
Co-Founder & CEO
Co-Founder & Head of Molecular Engineering
Co-Founder & Chief Scientific Officer